A research team at the University of Konstanz, led by toxicologist Ivano Amelio, has demonstrated how differently individual mutations of the tumor suppressor p53 affect pancreatic carcinomas.
p53 mutations show diverse impact on pancreatic cancer metabolism
- Post author:
- Post published:December 7, 2024
- Post category:uncategorized